Skip to main content
. Author manuscript; available in PMC: 2016 Sep 1.
Published in final edited form as: Toxicol Appl Pharmacol. 2015 Jun 3;287(2):149–160. doi: 10.1016/j.taap.2015.05.019

Figure 1.

Figure 1

Time to first tumor evaluated by cumulative tumor incidence function for each condition to account for any early non-cancer related mortalities in the study. The percent tumor bearing animals for all BaP, DBC and CTE treatments were significantly different from genotype-matched controls (p<5.048×10−6) as measured by Gray’s log rank test for equality with little effect from early mortality on incidence (p=0.4145).